Amy S. Determan

842 total citations
9 papers, 668 citations indexed

About

Amy S. Determan is a scholar working on Pharmaceutical Science, Molecular Biology and Dermatology. According to data from OpenAlex, Amy S. Determan has authored 9 papers receiving a total of 668 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Pharmaceutical Science, 5 papers in Molecular Biology and 2 papers in Dermatology. Recurrent topics in Amy S. Determan's work include Advanced Drug Delivery Systems (5 papers), Protein purification and stability (4 papers) and Advancements in Transdermal Drug Delivery (2 papers). Amy S. Determan is often cited by papers focused on Advanced Drug Delivery Systems (5 papers), Protein purification and stability (4 papers) and Advancements in Transdermal Drug Delivery (2 papers). Amy S. Determan collaborates with scholars based in United States and Italy. Amy S. Determan's co-authors include Balaji Narasimhan, Matt J. Kipper, Kris Hansen, Elizabeth Shen, Ying Zhang, Ken M. Brown, Marit Nilsen‐Hamilton, Victor S.‐Y. Lin, Brian G. Trewyn and Balaji Narasimhan and has published in prestigious journals such as Biomaterials, Journal of Controlled Release and Pharmaceutical Research.

In The Last Decade

Amy S. Determan

9 papers receiving 660 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Amy S. Determan United States 8 339 201 155 144 129 9 668
Akhilesh Kumar Shakya United States 18 199 0.6× 272 1.4× 217 1.4× 138 1.0× 146 1.1× 33 893
Ana Sara Cordeiro United Kingdom 16 529 1.6× 210 1.0× 219 1.4× 79 0.5× 240 1.9× 22 828
Juha Mönkäre Finland 14 579 1.7× 218 1.1× 223 1.4× 88 0.6× 271 2.1× 20 918
Aoife M. Rodgers United Kingdom 14 370 1.1× 180 0.9× 104 0.7× 41 0.3× 161 1.2× 23 672
Séverine Munier France 12 138 0.4× 255 1.3× 220 1.4× 108 0.8× 43 0.3× 15 514
Yanpu He United States 13 184 0.5× 290 1.4× 209 1.3× 62 0.4× 75 0.6× 21 676
Anthony P. Raphael Australia 18 615 1.8× 179 0.9× 187 1.2× 50 0.3× 404 3.1× 28 1.1k
Peipei Yang China 9 329 1.0× 158 0.8× 132 0.9× 50 0.3× 202 1.6× 12 654
Julianna Juhász Canada 13 246 0.7× 117 0.6× 41 0.3× 166 1.2× 73 0.6× 22 772
Julia Myschik New Zealand 11 109 0.3× 209 1.0× 176 1.1× 91 0.6× 44 0.3× 15 415

Countries citing papers authored by Amy S. Determan

Since Specialization
Citations

This map shows the geographic impact of Amy S. Determan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Amy S. Determan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Amy S. Determan more than expected).

Fields of papers citing papers by Amy S. Determan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Amy S. Determan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Amy S. Determan. The network helps show where Amy S. Determan may publish in the future.

Co-authorship network of co-authors of Amy S. Determan

This figure shows the co-authorship network connecting the top 25 collaborators of Amy S. Determan. A scholar is included among the top collaborators of Amy S. Determan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Amy S. Determan. Amy S. Determan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
Determan, Amy S., et al.. (2023). High‐performance countercurrent membrane purification for host cell protein removal from monoclonal antibody products. Biotechnology and Bioengineering. 120(12). 3585–3591. 3 indexed citations
2.
Kommareddy, Sushma, Barbara C. Baudner, Simona Gallorini, et al.. (2013). Influenza subunit vaccine coated microneedle patches elicit comparable immune responses to intramuscular injection in guinea pigs. Vaccine. 31(34). 3435–3441. 68 indexed citations
3.
Zhang, Ying, et al.. (2011). Development of Lidocaine-Coated Microneedle Product for Rapid, Safe, and Prolonged Local Analgesic Action. Pharmaceutical Research. 29(1). 170–177. 149 indexed citations
4.
Petersen, Latrisha K., et al.. (2011). Lipocalin-2-loaded amphiphilic polyanhydride microparticles accelerate cell migration.. PubMed. 22(9). 1237–52. 14 indexed citations
5.
Torres, María P., Amy S. Determan, Gretchen L. Anderson, Surya K. Mallapragada, & Balaji Narasimhan. (2006). Amphiphilic polyanhydrides for protein stabilization and release. Biomaterials. 28(1). 108–116. 90 indexed citations
6.
Determan, Amy S., et al.. (2006). Protein stability in the presence of polymer degradation products: Consequences for controlled release formulations. Biomaterials. 27(17). 3312–3320. 84 indexed citations
7.
Determan, Amy S., et al.. (2006). The role of microsphere fabrication methods on the stability and release kinetics of ovalbumin encapsulated in polyanhydride microspheres. Journal of Microencapsulation. 23(8). 832–843. 40 indexed citations
8.
Determan, Amy S., Brian G. Trewyn, Victor S.‐Y. Lin, Marit Nilsen‐Hamilton, & Balaji Narasimhan. (2004). Encapsulation, stabilization, and release of BSA-FITC from polyanhydride microspheres. Journal of Controlled Release. 100(1). 97–109. 103 indexed citations
9.
Kipper, Matt J., Elizabeth Shen, Amy S. Determan, & Balaji Narasimhan. (2002). Design of an injectable system based on bioerodible polyanhydride microspheres for sustained drug delivery. Biomaterials. 23(22). 4405–4412. 117 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026